Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Neuren Pharmaceuticals Limited has announced the application for quotation of 200,000 new ordinary fully paid securities under the ASX code ‘NEU,’ set to be issued on April 8, 2024. The company’s submission adheres to the ASX Listing Rules, indicating a new financial avenue for investors in the pharmaceutical sector.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
